Ex vivo assessment of drug response by differential staining cytotoxicity (DiSC) assay suggests a biological basis for equality of chemotherapy irrespective of age for patients with chronic lymphocytic leukaemia.

Source:http://linkedlifedata.com/resource/pubmed/id/10764159

Download in:

View as

General Info

PMID
10764159